ACE inhibitors
[대역어] ACE 억제제
[용어속성] Enzyme
[용어속성] Enzyme
Comorbidity Assessment Is Essential During COVID-19 Treatment
Physiology
[키워드] ACE inhibitors
affected
Analysis
assessment
blockers
cardiovascular disease
cardiovascular diseases
caused
Comorbidities
Comorbidity
Coronavirus disease 2019
country
COVID-19
death
Deceased
Deterioration
determine
diabete
diabetes
drug
dysfunction
endothelial
Endothelium
Essential
European
FIVE
France
Healthcare system
heart disease
hospital
Hospitalized
hospitalized patient
hypertension
immunodeficiency
individuals
Italy
Kidney disease
liver
Liver disease
losartan
Lung diseases
majority
medications
modulate
Mortality
Netherlands
neurological
outcome
Patient
proportion
retrieved
SARS-CoV2
severity
significantly higher
Spain
t -test
the disease
Treatment
with COVID-19
[DOI] 10.3389/fphys.2020.00984 PMC 바로가기 [Article Type] Physiology
[DOI] 10.3389/fphys.2020.00984 PMC 바로가기 [Article Type] Physiology
Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost
Review article
[키워드] ACE inhibitors
ACE-2
ACEangiotensin-converting enzyme
ACEIACE inhibitors
Acute lung injury/Acute respiratory distress syndrome
ADAlzheimer's disease
ALI/ARDSAcute lung injury/Acute respiratory distress syndrome
Alzheimer's disease
Angangiotensin
angiotensin
Angiotensin II receptor type 1
Angiotensin II Receptor Type 2
Angiotensin receptor blockers
Angiotensin-converting enzyme
ARBsAngiotensin receptor blockers
AT1RAngiotensin II receptor type 1
AT2RAngiotensin II receptor type 2
Aββ-amyloid
benefit
BKsBradykinins
Bradykinin receptor
Bradykinins
BRBradykinin receptor
caused
chloroquine/hydroxychloroquine
clinical study
components
Coronavirus disease 2019
COVID-19
COVID-19 pathogenesis
COVID-19coronavirus disease 2019
CQ/HCQChloroquine/Hydroxychloroquine
ECsEndothelial cells
Effect
effective
effort
endothelial cells
endothelial Nitric oxide synthase
Endothelin-1
eNOSendothelial Nitric oxide synthase
ET-1Endothelin-1
Evidence
fibrosis
fMLPformyl Methionyl-meucyl-proline
formyl Methionyl-meucyl-proline
G protein-coupled
Gastrin-releasing peptide
GM-CSFGranulocyte-macrophage colony-stimulating factor
GPCRG protein-coupled
granulocyte-macrophage colony-stimulating factor
GRPGastrin-releasing peptide
Heme oxygenase-1
HO-1heme oxygenase-1
humans
ILInterleukin
interleukin
MAPK/ERKMitogen-activated protein kinases/ Extracellular signal-regulated kinases
Mas receptor
MasRMas receptor
MCP-1monocyte chemoattractant protein-1
MERSMiddle East Respiratory Syndrome
Middle East respiratory syndrome
Mitogen-activated protein kinases/ Extracellular signal-regulated kinases
molecular mechanisms
monocyte chemoattractant protein-1
NADPHNicotinamide adenine dinucleotide phosphate (reduced form)
Natriuretic peptides
NEPiNeprilysin inhibitors
NEPNeprilysin
neprilysin
Neprilysin inhibitors
NF-kBNuclear factor kappa B
Nicotinamide adenine dinucleotide phosphate (reduced form)
nitric oxide
Non steroidal anti-inflammatory drugs
NONitric Oxide
NPsNatriuretic peptides
Nrf2nuclear factor erythroid 2–related factor 2
NSAIDsNon steroidal anti-inflammatory drugs
nuclear factor erythroid 2–related factor 2
nuclear factor kappa B
pandemic disease
pathophysiology
pathway
Peroxisome proliferator activator receptors
Phospholipase C beta/inositol trisphosphate
PLCb/IP3Phospholipase C beta/inositol trisphosphate
PNECsPulmonary neuroendocrine cells
PPARsPeroxisome proliferator activator receptors
protective effect
pulmonary inflammatory reaction
pulmonary neuroendocrine cells
RAS
RASRenin angiotensin system
reactive oxygen species
receptors
renin angiotensin system
Repurposed drug
researcher
ROSreactive oxygen species
SARS-CoV2
SARS-CoVsevere acute respiratory syndrome coronavirus
Selective estrogen receptor modulators
SERMsSelective estrogen receptor modulators
severe acute respiratory syndrome Coronavirus
severe pneumonia
Streptozotocin
STZStreptozotocin
suggested
targeting
TGF-β1Transforming growth factor- β1
therapeutic intervention
therapy
TNFTumor Necrosis Factor
Transforming growth factor- β1
treatment approaches
tumor necrosis factor
Vaccine
vascular endothelial growth factor
VEGFvascular endothelial growth factor
β-amyloid
[DOI] 10.1016/j.bcp.2020.114057 [Article Type] Review article
[DOI] 10.1016/j.bcp.2020.114057 [Article Type] Review article
COvid MEdicaTion (COMET) study: protocol for a cohort study
COvid MEdicaTion(COMET) 연구: 코호트 연구를 위한 프로토콜
Observational Study
[키워드] ACE inhibitor
ACE inhibitors
ACE2
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
adjusted
adverse effects
age
Angiotensin II
ARB
ARBs
binding
blocker
breath
cardiovascular disease
circulating
clinical evidence
Clinical outcome
clinical outcomes
clinical pharmacy
cohort study
collected
coronavirus
COVID-19
database
diabetes
Digitalis
drug
Europe
Evidence
facilitate
hospital
hypertension
Invasion
media
patients with COVID-19
protocol
randomised controlled trial
Randomised controlled trials
receptor
Receptor Blockers
respiratory
SARS-CoV-2
SARS-CoV-2 cell
severe acute respiratory syndrome Coronavirus
Sex
Spike protein
therapeutic strategy
vascular medicine
Viral
viral spike protein
Virology
[DOI] 10.1136/ejhpharm-2020-002329 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1136/ejhpharm-2020-002329 PMC 바로가기 [Article Type] Observational Study
The angiotensin-converting enzyme 2 (ACE2) receptor in the prevention and treatment of COVID-19 are distinctly different paradigms
Letter to the Editor
[키워드] ACE
ACE inhibitor
ACE inhibitors
ACE2
ACE2 receptor
activate
Angiotensin-converting enzyme
angiotensin-converting enzyme 2
angiotensin-converting enzyme inhibitor
ARB
ARBs
binding
blocker
cellular
Compound
concerning
contribute
coronavirus
COVID-19
COVID-19 infection
down-regulation
expression
hypertension
hypertensive
increase viral load
Infection
inhibitor
management
metformin
Mortality
normotensive
organ
pathology
patients
Perspective
pro-inflammatory
receptor
reflect
responsible
resveratrol
SAR-CoV2
SIRT1
Treatment
viral spike
Vitamin
Vitamin C
Vitamin D
[DOI] 10.1186/s40885-020-00147-x PMC 바로가기 [Article Type] Letter to the Editor
[DOI] 10.1186/s40885-020-00147-x PMC 바로가기 [Article Type] Letter to the Editor
Acute Kidney Injury in a Case Series of Patients with Confirmed COVID-19 (Coronavirus Disease 2019): Role of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Blockade
Case Series
[키워드] ACE inhibitor
ACE inhibitors
ACE2
Acute kidney injury
administration
African
angiotensin receptor blocker
Angiotensin receptor blockers
angiotensin-converting enzyme 2
angiotensin-converting enzyme inhibitor
ARB
blockade
cardiac damage
case sery
Confirmed
contributing to
coronavirus disease
COVID-19
Critical
diabetes
died
diuretics
Factor
Heart diseases
hemodynamic instability
human cell
hypertension
hypothese
implicated
Infection
kidney
men
Pathogenesis
Patient
patients with COVID-19
presenting
progression
raised
RAS
renal
renin-angiotensin system
respiratory symptom
role
Sery
survived
System
viral entry
[DOI] 10.1155/2020/8811931 PMC 바로가기 [Article Type] Case Series
[DOI] 10.1155/2020/8811931 PMC 바로가기 [Article Type] Case Series
Advanced bioinformatics rapidly identifies existing therapeutics for patients with coronavirus disease-2019 (COVID-19)
Research
[키워드] ACE inhibitors
ACE1
ACE2
ACE2 binding
acute respiratory syndrome
animal model
antibiotic
antiviral agent
applied
artificial intelligence
attenuate
benefit
binding
binding affinity
bioinformatics
blocking virus entry
caused
Cell
Compound
computational approach
Computational biology
coronavirus
Coronaviruses
COVID-19
DCT
disease-associated
drug
drug therapy
Effect
Effects
emerging disease
Emricasan
FDA approved drug
Fosamprenavir
Gene Expression
gene expression pattern
global pandemic
Glutamine
glutathione
highlight
identify
independent
induce
Infection
Patient
platform
precursor
Prevent
protective effect
Result
ruxolitinib
SARS-CoV
SARS-CoV-2
second
specificity
technology
therapeutic agent
TMPRSS2
translation
Vitamin E
while
[DOI] 10.1186/s12967-020-02430-9 PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s12967-020-02430-9 PMC 바로가기 [Article Type] Research
SARS-CoV-2 and diabetes: New challenges for the disease
Article
[키워드] ACE inhibitors
ACE-2
COVID-19
diabetes
glycemic control
SARS-CoV-2
[DOI] 10.1016/j.diabres.2020.108228 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.diabres.2020.108228 PMC 바로가기 [Article Type] Article
Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19
Article
[키워드] ACE inhibitors
angiotensin
angiotensin-converting enzyme inhibitors
COVID-19
hypertension
renin angiotensin system
renin-angiotensin system
severe acute respiratory syndrome coronavirus 2
Virology
[DOI] 10.2215/CJN.03530320 PMC 바로가기
[DOI] 10.2215/CJN.03530320 PMC 바로가기
Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox
Letter to the Editor
[키워드] ACE inhibitors
ARB
COVID-19
inhibitor
receptor
[DOI] 10.1017/ice.2020.195 PMC 바로가기 [Article Type] Letter to the Editor
[DOI] 10.1017/ice.2020.195 PMC 바로가기 [Article Type] Letter to the Editor